O'Shaughnessy Asset Management, LLC Harvard Bioscience Inc Transaction History
O'Shaughnessy Asset Management, LLC
- $8.9 Billion
- Q1 2024
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 15,502 shares of HBIO stock, worth $43,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,502
Previous 17,504
11.44%
Holding current value
$43,250
Previous $93,000
30.11%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding HBIO
# of Institutions
92Shares Held
32.8MCall Options Held
4KPut Options Held
2.2K-
B. Riley Asset Management, LLC Dallas, TX2.83MShares$7.91 Million5.14% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$7.91 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.73 Million0.71% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.14 Million1.17% of portfolio
-
Amh Equity LTD2.32MShares$6.48 Million10.16% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $116M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...